Jillian B. Thomsen, Chief Financial Officer at NEKTAR THERAPEUTICS (NKTR), sold 11,095 shares at $3.57 ($40K) on 2022-11-16, disclosed to the SEC on 2022-11-18.
Seasonal sale ($40k) by Chief Financial Officer — this insider has traded NKTR in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NKTR | SELL | 2022-05-17 | $23K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $26K | — | Filing → |
| NKTR | SELL | 2021-11-17 | $177K | — | Filing → |